The Cigna Group (CI) Expected to Announce Quarterly Earnings on Friday

The Cigna Group (NYSE:CI - Get Free Report) is expected to release its Q1 2025 earnings data before the market opens on Friday, May 2nd. Analysts expect The Cigna Group to post earnings of $6.41 per share and revenue of $60.39 billion for the quarter. The Cigna Group has set its FY 2025 guidance at 29.500- EPS.

The Cigna Group (NYSE:CI - Get Free Report) last released its quarterly earnings data on Thursday, January 30th. The health services provider reported $6.64 EPS for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same period last year, the company posted $6.79 earnings per share. On average, analysts expect The Cigna Group to post $30 EPS for the current fiscal year and $33 EPS for the next fiscal year.

The Cigna Group Stock Performance

NYSE CI traded up $3.00 on Wednesday, hitting $340.21. 1,562,618 shares of the stock were exchanged, compared to its average volume of 1,704,146. The company has a market capitalization of $93.11 billion, a PE ratio of 27.79, a P/E/G ratio of 0.98 and a beta of 0.51. The company has a debt-to-equity ratio of 0.70, a current ratio of 0.66 and a quick ratio of 0.72. The business's fifty day moving average is $322.13 and its 200 day moving average is $310.45. The Cigna Group has a 52 week low of $262.03 and a 52 week high of $370.83.

The Cigna Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 18th. Stockholders of record on Tuesday, June 3rd will be paid a dividend of $1.51 per share. The ex-dividend date of this dividend is Tuesday, June 3rd. This represents a $6.04 annualized dividend and a dividend yield of 1.78%. The Cigna Group's dividend payout ratio is presently 49.35%.

Insider Buying and Selling

In other The Cigna Group news, Director Elder Granger sold 2,376 shares of The Cigna Group stock in a transaction dated Friday, March 14th. The stock was sold at an average price of $310.35, for a total value of $737,391.60. Following the transaction, the director now owns 5,471 shares in the company, valued at $1,697,924.85. The trade was a 30.28 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO David Cordani sold 26,527 shares of the stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $308.12, for a total transaction of $8,173,499.24. Following the completion of the transaction, the chief executive officer now directly owns 127,767 shares of the company's stock, valued at $39,367,568.04. This trade represents a 17.19 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 43,751 shares of company stock valued at $13,603,991 over the last quarter. 0.70% of the stock is owned by company insiders.

Hedge Funds Weigh In On The Cigna Group

A hedge fund recently raised its stake in The Cigna Group stock. Brighton Jones LLC lifted its stake in shares of The Cigna Group (NYSE:CI - Free Report) by 9.3% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 3,736 shares of the health services provider's stock after buying an additional 318 shares during the period. Brighton Jones LLC's holdings in The Cigna Group were worth $1,032,000 as of its most recent SEC filing. 86.99% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

CI has been the subject of a number of research analyst reports. Robert W. Baird reduced their price target on The Cigna Group from $388.00 to $362.00 and set an "outperform" rating for the company in a report on Tuesday, April 15th. Morgan Stanley decreased their target price on The Cigna Group from $403.00 to $379.00 and set an "overweight" rating on the stock in a report on Friday, January 31st. StockNews.com raised The Cigna Group from a "buy" rating to a "strong-buy" rating in a report on Tuesday, April 8th. Stephens decreased their price objective on shares of The Cigna Group from $410.00 to $380.00 and set an "overweight" rating on the stock in a report on Friday, January 31st. Finally, Piper Sandler reissued an "overweight" rating and issued a $348.00 price objective (down from $394.00) on shares of The Cigna Group in a research report on Monday, February 3rd. Two equities research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and three have given a strong buy rating to the stock. Based on data from MarketBeat.com, The Cigna Group currently has an average rating of "Buy" and an average target price of $373.56.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.